MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Dunno if this Helps - in USA Hepititus surging in Children !

<< Previous

Bullboard Posts

Next >>

Comment by EtheGreaton Apr 26, 2022 9:22am

78 Views

Post# 34631594

RE:RE:Dunno if this Helps - in USA Hepititus surging in Children !

'august202013' correct me if I'm Wrong - but it's my understanding Medmira HIV & Hepititus Tests are already Approved in USA under EUA for Medical Environments for many Yrs now (so Medmira should be able to Up-Sell Now Immediately) , and New Clinical Trials are for All Purpose Authorization including General Public so that New Reveal Branded Versions can be Sold directly to Public or Over the Counter... -- EtheGreat or Not ?

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023